ACVBP Plus Rituximab in Patients Aged From 18 to 59 Years With High-risk Diffuse Large B-cell Lymphoma

Clinical trial NCT00144807 · COMPLETED

Trial details

NCT number: NCT00144807
Sponsor: Lymphoma Study Association
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Diffuse Large Cell Lymphoma

Start date: 2003-12-01
Primary completion: 2008-09-01
Enrollment: 128

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.